|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01030966
|
2-carboxy-cis,cis-muconic acid
|
(3Z)-buta-1,3-diene-1,1,4-tricarboxylic acid
|
FA 7:4;O4
|
C7H6O6
|
186.016440
|
|
LMFA03060107
|
5,15-DiHETE
|
(6E,8Z,11Z,13E)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03060107
|
5,15-DiHETE
|
(6E,8Z,11Z,13E)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA03060107
|
5,15-DiHETE
|
(6E,8Z,11Z,13E)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid
|
FA 20:4;O2
|
C20H32O4
|
336.230061
|
|
LMFA01050439
|
(+)-threo-2-Amino-3,4-dihydroxybutanoic acid
|
2-amino-3,4-dihydroxybutanoic acid
|
|
C4H9NO4
|
135.053159
|
|
LMFA01050439
|
(+)-threo-2-Amino-3,4-dihydroxybutanoic acid
|
2-amino-3,4-dihydroxybutanoic acid
|
|
C4H9NO4
|
135.053159
|
|
LMFA01050468
|
2,3-Dihydroxy-2-methylbutanoic acid
|
2,3-dihydroxy-2-methylbutanoic acid
|
FA 5:0;O2
|
C5H10O4
|
134.057910
|
|
LMFA01050468
|
2,3-Dihydroxy-2-methylbutanoic acid
|
2,3-dihydroxy-2-methylbutanoic acid
|
FA 5:0;O2
|
C5H10O4
|
134.057910
|
|
LMFA01030943
|
(2Z,4Z)-2-hydroxyhexa-2,4-dienoic acid
|
(2Z,4Z)-2-hydroxyhexa-2,4-dienoic acid
|
FA 6:2;O
|
C6H8O3
|
128.047345
|
|
LMFA01030943
|
(2Z,4Z)-2-hydroxyhexa-2,4-dienoic acid
|
(2Z,4Z)-2-hydroxyhexa-2,4-dienoic acid
|
FA 6:2;O
|
C6H8O3
|
128.047345
|
|
LMFA01030989
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
FA 8:4;O4
|
C8H8O6
|
200.032090
|
|
LMFA01030989
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
5-formyl-2-hydroxyhepta-2,4-dienedioic acid
|
FA 8:4;O4
|
C8H8O6
|
200.032090
|
|
LMFA05000596
|
1-Acetoxy-2-hydroxy-5,12,15-heneicosatrien-4-one
|
(2R,5E,12Z,15Z)-2-hydroxy-4-oxohenicosa-5,12,15-trien-1-yl acetate
|
FOH 23:5;O3
|
C23H38O4
|
378.277011
|
|
LMFA01050479
|
2-hydroxy-3-oxoadipic acid
|
2-hydroxy-3-oxohexanedioic acid
|
FA 6:2;O4
|
C6H8O6
|
176.032090
|
|
LMFA01050479
|
2-hydroxy-3-oxoadipic acid
|
2-hydroxy-3-oxohexanedioic acid
|
FA 6:2;O4
|
C6H8O6
|
176.032090
|
|
LMFA08020197
|
Palmitoyl Serinol
|
N-(1,3-dihydroxypropan-2-yl)hexadecanamide
|
NA 19:0;O2
|
C19H39NO3
|
329.292994
|
|
LMFA08020197
|
Palmitoyl Serinol
|
N-(1,3-dihydroxypropan-2-yl)hexadecanamide
|
NA 19:0;O2
|
C19H39NO3
|
329.292994
|
|
LMFA07070055
|
Docosa-4E,7E,10E,13E,16E,19E-hexaenoylcarnitine
|
3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 22:6
|
C29H45NO4
|
471.334859
|
|
LMFA07070055
|
Docosa-4E,7E,10E,13E,16E,19E-hexaenoylcarnitine
|
3-[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 22:6
|
C29H45NO4
|
471.334859
|
|
LMFA07010758
|
3-Methylbutyl decanoate
|
3-methylbutyl decanoate
|
WE 15:0
|
C15H30O2
|
242.224581
|
|
LMFA07010758
|
3-Methylbutyl decanoate
|
3-methylbutyl decanoate
|
WE 15:0
|
C15H30O2
|
242.224581
|
|
LMFA07010809
|
cis-3-Hexenyl trans-2-hexenoate
|
(3Z)-hex-3-en-1-yl (2E)-hex-2-enoate
|
WE 12:2
|
C12H20O2
|
196.146330
|
|
LMFA07010809
|
cis-3-Hexenyl trans-2-hexenoate
|
(3Z)-hex-3-en-1-yl (2E)-hex-2-enoate
|
WE 12:2
|
C12H20O2
|
196.146330
|
|
LMFA07010806
|
cis-3-Hexenyl crotonate
|
(3Z)-hex-3-en-1-yl (2E)-but-2-enoate
|
WE 10:2
|
C10H16O2
|
168.115030
|
|
LMFA07010806
|
cis-3-Hexenyl crotonate
|
(3Z)-hex-3-en-1-yl (2E)-but-2-enoate
|
WE 10:2
|
C10H16O2
|
168.115030
|
|
LMFA07050148
|
(R)-3-hydroxybutanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(3R)-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 4:0;O
|
C25H42N7O18P3S
|
853.151989
|
|
LMFA07050148
|
(R)-3-hydroxybutanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(3R)-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 4:0;O
|
C25H42N7O18P3S
|
853.151989
|
|
LMFA07050148
|
(R)-3-hydroxybutanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(3R)-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 4:0;O
|
C25H42N7O18P3S
|
853.151989
|
|
LMFA07050148
|
(R)-3-hydroxybutanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(3R)-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 4:0;O
|
C25H42N7O18P3S
|
853.151989
|
|
LMFA07050148
|
(R)-3-hydroxybutanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(3R)-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 4:0;O
|
C25H42N7O18P3S
|
853.151989
|
|
LMFA07050148
|
(R)-3-hydroxybutanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(3R)-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 4:0;O
|
C25H42N7O18P3S
|
853.151989
|
|
LMFA07050135
|
(9Z)-myristoleoyl-CoA
|
9Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050135
|
(9Z)-myristoleoyl-CoA
|
9Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050135
|
(9Z)-myristoleoyl-CoA
|
9Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050135
|
(9Z)-myristoleoyl-CoA
|
9Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050135
|
(9Z)-myristoleoyl-CoA
|
9Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050135
|
(9Z)-myristoleoyl-CoA
|
9Z-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297925
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07050333
|
isopalmitoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(14-methylpentadecanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 16:0
|
C37H66N7O17P3S
|
1005.344875
|
|
LMFA07070103
|
pivaloylcarnitine
|
3-[(2,2-dimethylpropanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 5:0
|
C12H23NO4
|
245.162709
|
|
LMFA07070103
|
pivaloylcarnitine
|
3-[(2,2-dimethylpropanoyl)oxy]-4-(trimethylazaniumyl)butanoate
|
CAR 5:0
|
C12H23NO4
|
245.162709
|
|
LMFA04020064
|
(13R,16S,20S)-d18-14-NeuroF[14S,17S]
|
(R,4Z,7Z,10Z)-13-hydroxy-13-((2S,4S,5S)-4-hydroxy-5-((S,E)-3-hydroxypent-1-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,10-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA07011032
|
all-trans-retinyl linoleate
|
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (9Z,12Z)-octadec-9,12-enoate
|
WE 38:8
|
C38H60O2
|
548.459331
|
|
LMFA07011032
|
all-trans-retinyl linoleate
|
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (9Z,12Z)-octadec-9,12-enoate
|
WE 38:8
|
C38H60O2
|
548.459331
|
|
LMFA07050210
|
3-hydroxy-5-oxohexanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-5-oxohexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:1;O2
|
C27H44N7O19P3S
|
895.162554
|
|
LMFA07050210
|
3-hydroxy-5-oxohexanoyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxy-5-oxohexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 6:1;O2
|
C27H44N7O19P3S
|
895.162554
|